In the context of sarcoidosis these results provide new puzzle pieces of the largely unknown pathogenesis of this disease suggesting a role of IL-26 in the activation of moDCs via TLR2 followed by the secretion of TNF-α, an important pathological player and therapeutical target in sarcoidosis. This evidence concerns the gene TLR2 and sarcoidosis.